Add Company
Join Now

MOBILion Systems Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • MOBILion Systems's estimated annual revenue is currently $14.9M per year.(i)
  • MOBILion Systems's estimated revenue per employee is $155,000

Employee Data

  • MOBILion Systems has 96 Employees.(i)
  • MOBILion Systems grew their employee count by -8% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.6M100%N/AN/A
#2
$4M2613%N/AN/A
#3
$0.9M6-14%N/AN/A
#4
$1.1M70%N/AN/A
#5
$10.9M703%N/AN/A
#6
$0.7M929%N/AN/A
#7
$4M26-16%N/AN/A
#8
$1.7M1122%N/AN/A
#9
$7.6M492%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

MOBILion’s technology makes it easy to separate, identify and analyze the most challenging molecules that other instruments fail to detect. Our higher resolution, faster analysis and simpler workflows reveal molecules that are most important in characterizing biologic therapeutics, discovering biomarkers, and improving the accuracy of diagnostic tests. We make today’s treatment’s safer and more effective, empower tomorrow’s disease prediction and diagnosis, and accelerate the development of new therapies.

keywords:N/A

N/A

Total Funding

96

Number of Employees

$14.9M

Revenue (est)

-8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

MOBILion Systems's People

NameTitleEmail/Phone
1
Senior Director Applications & Market DevelopmentReveal Email/Phone
2
Director North American SalesReveal Email/Phone
3
Mechanical Engineering ManagerReveal Email/Phone
4
Senior Research and Development ScientistReveal Email/Phone
5
VP Product DevelopmentReveal Email/Phone
6
Senior Marketing Communications SpecialistReveal Email/Phone
7
Field Service ManagerReveal Email/Phone
8
Application ScientistReveal Email/Phone
9
VP R&DReveal Email/Phone
10
SVP, Digital & Software StrategyReveal Email/Phone
Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$21.1M965%N/A
#2
$15M9810%N/A
#3
$16.5M11427%N/A
#4
$31.3M116-8%N/A
#5
$24.6M1403%N/A